Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,480,416
-
Share change
-
+1,990,335
-
Total reported value
-
$33,820,000
-
Price per share
-
$1.83
-
Number of holders
-
13
-
Value change
-
+$3,059,025
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q3 2015
As of 30 Sep 2015,
PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,480,416 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Tekla Capital Management LLC, Lombard Odier Asset Management (USA) Corp, Omega Fund Management, LLC, EMERALD MUTUAL FUND ADVISERS TRUST, SPHERA FUNDS MANAGEMENT LTD., SABBY MANAGEMENT, LLC, EMERALD ADVISERS INC/PA, TFS CAPITAL LLC, and KCG Holdings, Inc..
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.